KR20080072748A - 줄기세포 귀소 및 생착을 향상시키는 방법 - Google Patents

줄기세포 귀소 및 생착을 향상시키는 방법 Download PDF

Info

Publication number
KR20080072748A
KR20080072748A KR1020087015455A KR20087015455A KR20080072748A KR 20080072748 A KR20080072748 A KR 20080072748A KR 1020087015455 A KR1020087015455 A KR 1020087015455A KR 20087015455 A KR20087015455 A KR 20087015455A KR 20080072748 A KR20080072748 A KR 20080072748A
Authority
KR
South Korea
Prior art keywords
cells
group
stem
nicotinamide
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020087015455A
Other languages
English (en)
Korean (ko)
Inventor
토니 펠레드
Original Assignee
가미다-셀 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 가미다-셀 리미티드 filed Critical 가미다-셀 리미티드
Publication of KR20080072748A publication Critical patent/KR20080072748A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020087015455A 2005-11-29 2006-11-29 줄기세포 귀소 및 생착을 향상시키는 방법 Ceased KR20080072748A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28900405A 2005-11-29 2005-11-29
US11/289,004 2005-11-29

Publications (1)

Publication Number Publication Date
KR20080072748A true KR20080072748A (ko) 2008-08-06

Family

ID=37895790

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087015455A Ceased KR20080072748A (ko) 2005-11-29 2006-11-29 줄기세포 귀소 및 생착을 향상시키는 방법

Country Status (9)

Country Link
EP (2) EP1974012B1 (https=)
JP (1) JP5102773B2 (https=)
KR (1) KR20080072748A (https=)
AU (1) AU2006321172B2 (https=)
BR (1) BRPI0620523A2 (https=)
CA (1) CA2632288A1 (https=)
ES (1) ES2409128T3 (https=)
WO (1) WO2007063545A2 (https=)
ZA (1) ZA200805210B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003523166A (ja) 1998-09-29 2003-08-05 ガミダ セル リミテッド 幹細胞および前駆細胞の増殖と分化を制御する方法
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
JP5763894B2 (ja) * 2009-07-01 2015-08-12 タカラバイオ株式会社 細胞の分離方法
US20130011376A1 (en) * 2009-12-29 2013-01-10 Gamida Cell Ltd. Methods for Enhancing Natural Killer Cell Proliferation and Activity
WO2012121451A1 (ko) * 2011-03-08 2012-09-13 연세대학교 산학협력단 줄기세포의 인 비보 이동 유도방법
HK1202581A1 (en) 2012-02-13 2015-10-02 Gamida-Cell Ltd. Mesenchymal stem cells conditioned medium and methods of generating and using the same
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells
WO2018211487A1 (en) * 2017-05-16 2018-11-22 Gamida-Cell Ltd. Selection and use of umbilical cord cell fractions suitable for transplantation
BR112019024113A2 (pt) 2017-05-16 2020-06-02 Gamida-Cell Ltd. Métodos para selecionar uma unidade de sangue do cordão umbilical e frações de célula sanguínea do cordão umbilical e para preparar uma unidade de sangue do cordão umbilical.

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
DE69637001T2 (de) 1995-06-07 2007-12-06 Bioveris Corp. Elektrochemilumineszenz-enzymimmunoassay
US6866842B1 (en) 1998-05-01 2005-03-15 University Of Pittsburgh Muscle-derived cells (MDCs) for treating muscle-or bone-related injury or dysfunction
US6713245B2 (en) 1998-07-06 2004-03-30 Diacrin, Inc. Methods for storing neural cells such that they are suitable for transplantation
JP2002538779A (ja) 1999-02-10 2002-11-19 キュリス インコーポレイテッド 膵臓細胞前駆細胞、それらに関する方法及び利用
US7045349B2 (en) 2001-01-23 2006-05-16 Benedict Daniel J Method of islet isolation using process control
IL152904A0 (en) * 2002-01-24 2003-06-24 Gamida Cell Ltd Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
WO2003078567A2 (en) * 2002-03-18 2003-09-25 Gamida-Cell Ltd. Methods of inducing differentiation in ex vivo expanded stem cells
MXPA05001992A (es) * 2002-08-19 2005-08-03 Gamida Cell Ltd Expansion ex-vivo de poblaciones de celulas de tallo, hematopoyeticas, en cultivos de celulas mononucleares.
US20050054103A1 (en) * 2003-03-07 2005-03-10 Tony Peled Expansion of renewable stem cell populations using modulators of PI 3-kinase
US20040247574A1 (en) 2003-05-27 2004-12-09 Christopherson Kent W. Methods for enhancing stem cell engraftment during transplantation
IL161903A0 (en) * 2003-07-17 2005-11-20 Gamida Cell Ltd Ex vivo progenitor and stem cell expansion for usein the treatment of disease of endodermally- deri ved organs

Also Published As

Publication number Publication date
JP2009517078A (ja) 2009-04-30
AU2006321172A1 (en) 2007-06-07
JP5102773B2 (ja) 2012-12-19
WO2007063545A2 (en) 2007-06-07
WO2007063545A3 (en) 2007-07-19
BRPI0620523A2 (pt) 2011-11-16
AU2006321172B2 (en) 2012-02-23
ZA200805210B (en) 2009-09-30
EP1974012A2 (en) 2008-10-01
ES2409128T3 (es) 2013-06-25
EP2390312A1 (en) 2011-11-30
CA2632288A1 (en) 2007-06-07
EP1974012B1 (en) 2013-02-27

Similar Documents

Publication Publication Date Title
US8986744B2 (en) Stem cell populations and methods of use
EP0812201B1 (en) In vitro amplification of stem cells
Brandt et al. Ex vivo expansion of autologous bone marrow CD34+ cells with porcine microvascular endothelial cells results in a graft capable of rescuing lethally irradiated baboons
US20080118477A1 (en) Umbilical cord mesenchymal stem cells support cord blood hematopoiesis
Nakamura et al. Soluble c-kit receptor mobilizes hematopoietic stem cells to peripheral blood in mice
KR20110063640A (ko) 혈액 형성 전구 세포의 증식
JP2019170176A (ja) ケモカインレセプターと細胞接着分子を発現するｃｄ３陰性細胞の集団、およびその利用
US6821513B1 (en) Method for enhancing hematopoiesis
US8846393B2 (en) Methods of improving stem cell homing and engraftment
JP5102773B2 (ja) 幹細胞のホーミングおよび生着を改善する方法
WO2021131261A1 (ja) 細胞群及びその取得方法
Shih et al. Ex vivo expansion of transplantable human hematopoietic stem cells: where do we stand in the year 2000?
US20120065620A1 (en) Bone marrow extracellular matrix extract and therapeutic use thereof
US20070243171A1 (en) Biological Cell Culture, Cell Culture Media and Therapeutic Use of Biological Cells
Koury et al. Wintrobe’s clinical hematology
US20090298045A1 (en) Method For Selectively Expanding, Selecting And Enriching Stem/Progenitor Cell Populations
HK1164367A (en) Methods of improving stem cell homing and engraftment
JP2022017977A (ja) 細胞、組成物及び治療用組成物
WO2000078930A1 (en) Method for enhancing hematopoiesis
Case The cytokine-mediated expansion of human umbilical cord blood stem and progenitor cells
Oates Thrombopoietin mediated regulation of murine hematopoietic progenitors
Duckles et al. Handbook of Experimental Pharmacology

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20080625

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20111109

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20130620

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20130926

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20130620

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I